Weatherbie Capital Decreased Ultragenyx Pharmaceutical Inco (RARE) Position By $4.32 Million; Veritable LP Has Increased Pfizer (PFE) Stake By $588,832

June 20, 2017 - By Vivian Currie

Weatherbie Capital Llc decreased Ultragenyx Pharmaceutical Inco (RARE) stake by 26.76% reported in 2016Q4 SEC filing. Weatherbie Capital Llc sold 61,713 shares as Ultragenyx Pharmaceutical Inco (RARE)’s stock declined 25.28%. The Weatherbie Capital Llc holds 168,915 shares with $11.88M value, down from 230,628 last quarter. Ultragenyx Pharmaceutical Inco now has $2.82B valuation. The stock rose 2.10% or $1.34 reaching $65.21. About 248,061 shares traded. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has declined 6.49% since June 20, 2016 and is downtrending. It has underperformed by 23.19% the S&P500.

Veritable Lp increased Pfizer Inc (PFE) stake by 5.05% reported in 2016Q4 SEC filing. Veritable Lp acquired 18,401 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Veritable Lp holds 382,689 shares with $12.43 million value, up from 364,288 last quarter. Pfizer Inc now has $202.21B valuation. The stock rose 1.44% or $0.48 reaching $33.7 per share. About 17.03M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since June 20, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.05, from 1.18 in 2016Q3. It turned negative, as 60 investors sold PFE shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported. London Of Virginia, a Virginia-based fund reported 6.64M shares. Davidson And Garrard stated it has 1.37% of its portfolio in Pfizer Inc. (NYSE:PFE). General Investors Co holds 1.51% of its portfolio in Pfizer Inc. (NYSE:PFE) for 460,808 shares. Mariner Wealth Limited Liability Company owns 239,301 shares. Ibm Retirement Fund stated it has 565,871 shares or 0.81% of all its holdings. Zevin Asset Management Ltd Liability Corporation, a Massachusetts-based fund reported 10,433 shares. Johnson Inv Counsel invested 0.16% of its portfolio in Pfizer Inc. (NYSE:PFE). Cypress Asset Management Tx stated it has 1.56% in Pfizer Inc. (NYSE:PFE). Lvw Advsrs Ltd Liability Corporation invested in 82,620 shares or 0.94% of the stock. Marshwinds Advisory Communications accumulated 1.97% or 127,457 shares. Tctc Ltd stated it has 1.04 million shares or 2.06% of all its holdings. Ironwood Counsel Ltd Liability Corp holds 0.61% in Pfizer Inc. (NYSE:PFE) or 41,926 shares. American Asset Mngmt accumulated 14,929 shares. New England Private Wealth Ltd Llc has 19,648 shares for 0.22% of their portfolio. 1.28 million were accumulated by Nippon Life Insurance.

Veritable Lp decreased Berkshire Hathaway Inc Del (BRKA) stake by 4 shares to 64 valued at $15.62M in 2016Q4. It also reduced Digital Rlty Tr Inc (NYSE:DLR) stake by 5,126 shares and now owns 14,172 shares. Select Sector Spdr Tr (XLU) was reduced too.

Among 20 analysts covering Pfizer (NYSE:PFE), 7 have Buy rating, 1 Sell and 12 Hold. Therefore 35% are positive. Pfizer had 45 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Argus Research to “Hold” on Wednesday, November 2. The stock has “Neutral” rating by Societe Generale on Friday, March 24. Citigroup downgraded the stock to “Sell” rating in Tuesday, May 16 report. The firm has “Neutral” rating given on Monday, April 18 by Goldman Sachs. The firm has “Hold” rating by Jefferies given on Thursday, October 13. The stock of Pfizer Inc. (NYSE:PFE) has “Overweight” rating given on Friday, October 2 by Morgan Stanley. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Friday, August 14 with “Buy” rating. The rating was maintained by Credit Suisse with “Outperform” on Monday, May 9. The firm has “Hold” rating by S&P Research given on Wednesday, October 28. The firm has “Buy” rating by Jefferies given on Tuesday, June 14.

Since February 27, 2017, it had 0 insider buys, and 5 selling transactions for $5.16 million activity. JOHNSON RADY A also sold $153,855 worth of Pfizer Inc. (NYSE:PFE) on Friday, March 10. Dolsten Mikael also sold $2.02 million worth of Pfizer Inc. (NYSE:PFE) shares. $693,200 worth of stock was sold by LANKLER DOUGLAS M on Thursday, March 2. HILL CHARLES H also sold $1.23 million worth of Pfizer Inc. (NYSE:PFE) shares.

Among 14 analysts covering Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), 9 have Buy rating, 1 Sell and 4 Hold. Therefore 64% are positive. Ultragenyx Pharmaceutical Inc had 26 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Thursday, April 6. The firm has “Market Outperform” rating given on Wednesday, June 8 by JMP Securities. The firm earned “Outperform” rating on Tuesday, May 10 by Wedbush. On Tuesday, August 18 the stock rating was downgraded by Zacks to “Buy”. The rating was initiated by Bank of America on Tuesday, June 28 with “Buy”. The rating was downgraded by Citigroup to “Sell” on Monday, November 14. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, December 1. The company was initiated on Tuesday, December 22 by Canaccord Genuity. The firm has “Neutral” rating by H.C. Wainwright given on Wednesday, April 19. On Thursday, March 23 the stock rating was downgraded by PiperJaffray to “Neutral”.

Weatherbie Capital Llc increased U S Physical Therapy Inc Com (NYSE:USPH) stake by 92,607 shares to 198,198 valued at $13.91M in 2016Q4. It also upped Wayfair Inc (NYSE:W) stake by 42,465 shares and now owns 698,802 shares. Insulet Corp Com (NASDAQ:PODD) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: